antiemetic/vomiting

RELATED APPLICATIONS This application is a U.S. National Phase application, filed under 35 U.S.C. .sctn. 371(c), of International Application No. PCT/GB2016/050998, filed on Apr. 11, 2016, which claims the benefit of and priority to United Kingdom Patent Application No. 1506116.1, filed on Apr. 10,

This application is a National Stage Application of PCT/IN2008/000704, filed Oct. 24, 2008, which claims benefit of Serial No. 1460/KOL/2007, filed Oct. 25, 2007 in India and which applications are incorporated herein by reference. To the extent appropriate, a claim of priority is made to each of

FIELD OF THE INVENTION The present invention comprises anti-emetic compositions and related methods for using same. More specifically, the present invention relates to compositions having more than one anti-emetic ingredient, which act synergistically and/or additively to relieve symptoms associated

FIELD OF THE INVENTION The present invention relates to both a therapeutic composition comprising a combination of antiemetic drugs and to a method for treating emesis, including nausea. BACKGROUND OF THE INVENTION Nausea and vomiting can follow the administration of many drugs, particularly

FIELD OF THE INVENTION This invention is in the field of pharmacology, and relates to anti-emetic drugs, i.e., drugs that suppress nausea and vomiting. BACKGROUND OF THE INVENTION "Emesis" and "emetic" refer to the process commonly known as vomiting or retching, wherein the stomach is evacuated

FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

FIELD OF THE INVENTION This invention relates to the use of amisulpride in the therapy of nausea, vomiting and retching. BACKGROUND OF THE INVENTION Emesis is the act of vomiting and can be described as the forceful expulsion of gastrointestinal contents through the mouth brought about by the

BACKGROUND OF THE INVENTION This invention relates to a method of preventing emesis in mammals. More specifically, this invention relates to the use of the known compound anti-8-N-methyl-piperazinyl-N'-carbonyldibenzobicyclo[3.2.1]octadiene and its pharmaceutically acceptable acid addition salts as

The present invention relates to the use of a class of substituted triazolo-pyridazine derivatives in therapy. More particularly, this invention is concerned with the use of substituted 1,2,4-triazolo[4,3-b]pyridazine derivatives which are ligands for GABA.sub.A receptors in the treatment and/or

BACKGROUND OF THE INVENTION This invention is concerned with compounds of structural formula I: ##STR1## wherein X is --CH.dbd.CH--, --CH.sub.2 --CH.sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --S--CH.sub.2 --, --CH.sub.2 --S--, --S-- or --O--, and R is a 5- or 6-membered nitrogen heterocyclic

BACKGROUND OF THE INVENTION This invention is concerned with compounds of structural formula I: ##STR1## wherein X is --CH.dbd.CH--, --CH.sub.2 --CH.sub.2 --, --CH.sub.2 --O--, --O--CH.sub.2 --, --S--CH.sub.2 --, --CH.sub.2 --S--, --S-- or --O--, and R is a 5- or 6-membered nitrogen heterocyclic

CROSS-REFERENCE TO RELATED APPLICATIONS Not applicable. STATEMENT REGARDING FEDERALLY SPONSERED RESEARCH OR DEVELOPMENT Not applicable. REFERENCE TO A MICROFICHE APPENDIX Not applicable. BACKGROUND OF THE INVENTION 1. Field of the Invention A new use for estrone, derivatives of estrone, equilin and